DNA vaccine and duck eggs protect against hantavirus disease

Army scientists and industry collaborators have successfully protected laboratory animals from lethal hantavirus disease using a novel approach that combines DNA vaccines and duck eggs. The work appears in a recent edition of the online scientific journal PLoS ONE, published by the Public Library of Science.

According to first author Jay W. Hooper of the U.S. Army Medical Research Institute of Infectious Diseases (USAMRIID), this is the first time that the DNA vaccine/duck egg system has been shown to produce an antiviral product capable of protecting against hantavirus disease.

Hantavirus causes a condition known as hantavirus pulmonary syndrome (HPS), which has a case fatality rate of 35-40 percent. Currently there are no vaccines, prophylactics, or therapeutics to prevent or treat this highly pathogenic disease.

In this study, the research team used a hamster model of Andes virus, which is the predominant cause of HPS in South America and the only hantavirus known to be transmitted person-to-person. Infection of Syrian hamsters with Andes virus, as demonstrated in earlier studies at USAMRIID, results in a disease that closely mimics human HPS in incubation time, symptoms of respiratory distress, and . This makes it an ideal system for evaluating the feasibility of postexposure protection strategies.

Collaborating with Aldevron of Fargo, N.D. and the Universidad del Desarrollo in Santiago, Chile, Hooper and his team first evaluated a natural product, human polyclonal antibody, which was obtained as fresh frozen plasma (FFP) from a patient who survived HPS. Their results indicate that FFP shows promise as a post-exposure preventive treatment for HPS.

The team then vaccinated ducks with a DNA vaccine against Andes virus. This vaccine, initially developed and tested at USAMRIID, uses genetic material, or DNA, that encodes a specific hantavirus gene to elicit an immune response in the recipient.

Next, they purified an antibody called IgY from the yolks of the duck eggs. This purified IgY, as well as a similar version produced in , was capable of neutralizing Andes virus when tested in cell culture. More importantly, it also protected Syrian hamsters from lethal HPS—even when administered as a single injection several days after the hamsters had been exposed to a lethal dose of virus.

The work demonstrates the feasibility of using DNA vaccine technology, coupled with the duck/egg system, to manufacture a product that could supplement or replace FFP. Furthermore, the new approach can be scaled as needed and eliminates the necessity of using blood products from HPS survivors, which may be in limited supply.

According to Hooper, another advantage of this technique is that duck IgY naturally loses a part of the antibody that has been associated with "serum sickness" when animal antibodies have been used in humans, making the product potentially less reactogenic.

"This antiviral product, if fully developed and manufactured, has the potential to be used in future outbreak situations," Hooper said. "It also could be used to treat health care workers and others who have close contact with HPS patients."

In addition, the authors suggest, the flexibility of the /duck egg system could be applied to the production of antibodies against other infectious agents and toxins.

More information: Brocato R, Josleyn M, Ballantyne J, Vial P, Hooper JW (2012). DNA Vaccine-Generated Duck Polyclonal Antibodies as a Postexposure Prophylactic to Prevent Hantavirus Pulmonary Syndrome (HPS). PLoS One 7(4): e35996. doi: 10.1371/journal.pone.0035996

add to favorites email to friend print save as pdf

Related Stories

Can hantavirus infection spread among humans?

Jan 18, 2008

In connection with last year's epidemic, a research team at Umea University in Sweden has managed for the first time to show that hantavirus exists in human saliva. This raises the question of whether this contagion can spread ...

Smallpox vaccine alternative identified

Jan 07, 2008

University of California, Irvine infectious disease researchers have shown the effectiveness of a potential alternative to the existing smallpox vaccine that can replace the current biodefense stockpile for this lethal virus.

Hantavirus found in African wood mouse

Apr 18, 2006

Scientists have reported the discovery of the first African hantavirus, a type of rodent-borne virus that can cause life-threatening infections in humans.

Recommended for you

Restrictions lifted at British bird flu farm

15 hours ago

Britain on Sunday lifted all restrictions at a duck farm in northern England after last month's outbreak of H5N8 bird flu, the same strain seen in recent cases across Europe.

Recorded Ebola deaths top 7,000

Dec 20, 2014

The worst Ebola outbreak on record has now killed more than 7,000 people, with many of the latest deaths reported in Sierra Leone, the World Health Organization said as United Nations Secretary-General Ban ...

Liberia holds Senate vote amid Ebola fears (Update)

Dec 20, 2014

Health workers manned polling stations across Liberia on Saturday as voters cast their ballots in a twice-delayed Senate election that has been criticized for its potential to spread the deadly Ebola disease.

Evidence-based recs issued for systemic care in psoriasis

Dec 19, 2014

(HealthDay)—For appropriately selected patients with psoriasis, combining biologics with other systemic treatments, including phototherapy, oral medications, or other biologic, may result in greater efficacy ...

User comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.